23andMe CEO addresses FDA setback

23andMe CEO Anne Wojcicki talks about the challenges her company faces in working with the FDA to get approval to market its DNA kits.

  • untitled
This video series features interviews with C-Level executives, high-level business leaders and policy makers covering strategy and current affairs from the perspective of the corner office.